In this retrospective study, Rassweiler et al. evaluated the long-term efficacy of high-energy shock wave therapy (HESWT) in managing chronic-phase Peyronie's disease (PD) using two different electromagnetic lithotripters. The study included 82 patients treated between 1999 and 2008, divided into two groups based on the lithotripter used: the Modulith SLX
